Journal of Medical Genetics · 2008 · 88 citations · 23 references
MedicineOncologySurgeryCancer EpidemiologyCancer PreventionCancer ScreeningBreast Cancer Risk AssessmentBreast Cancer SurgeryBreast SurgeryCancer RiskGenetic Risk AssessmentRisk ReductionControl Group DesignGenetic Risk-reducing SurgeryIncidence RateIncidence Rate EstimationLifetime Risk EstimationMatched Control GroupOccult MalignancyRisk-reducing Mastectomy
BACKGROUND: Increasingly women at high risk of breast cancer are opting for risk reducing surgery. The aim of this study was to assess the effectiveness of this approach in women at high risk in both carriers and non-carriers of BRCA1/2. METHODS: Data from 10 European centres that offer a genetic counselling and screening service to women at risk were obtained prospectively from 1995. Breast cancer risks were estimated from life tables and a control group of women at risk who did not undergo surgery. RESULTS: The combined centres have data on 550 women who have undergone risk reducing mastectomy with greater than 3334 women years of follow-up. Operations were carried out on women with lifetime risks of 25-80%, with an average expected incidence rate of 1% per year. No breast cancers have occurred in this cohort in the "at risk" unaffected breast, whereas >34 would have been expected. A high rate (2-3.6%) of occult disease was identified in the at risk breast at the time of surgery. INTERPRETATION: We conclude that risk reducing surgery is highly effective.
23
Risks of cancer in BRCA1-mutation carriers
Daniel Ford · The Lancet · 1994 · 1.9K citations
Life Sciences, Genetics, Oncology +12
Prophylactic Oophorectomy in Carriers of<i>BRCA1</i>or<i>BRCA2</i>Mutations
Timothy R. Rebbeck, Henry T. Lynch, Susan L. Neuhausen et al. · New England Journal of Medicine · 2002 · 1.5K citations
Medicine, Gynecology, Surgery +16